Drug Shortage Report for SODIUM BICARBONATE INJECTION USP

Last updated on 2020-02-04 History
Report ID 100930
Drug Identification Number 00261998
Brand name SODIUM BICARBONATE INJECTION USP
Common or Proper name Sodium Bicarbonate Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) SODIUM BICARBONATE
Strength(s) 84MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 10mL LifeShield Syringe
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-03
Estimated end date
Actual end date 2020-02-03
Shortage status Resolved
Updated date 2020-02-04
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-02-04 English Compare
v9 2020-02-03 French Compare
v8 2020-02-03 English Compare
v7 2020-01-28 French Compare
v6 2020-01-28 English Compare
v5 2020-01-06 French Compare
v4 2020-01-06 English Compare
v3 2020-01-04 English Compare
v2 2019-12-11 French Compare
v1 2019-12-11 English Compare